MYOCD and lung carcinoma: To model clinical settings of MYOCD deletion in lung cancer, we tested the impact of MYOCD knockout on lung cancer development using lsl-KrasG12D transgenic mice, a model widely accepted to faithfully recapitulate the clinical course of lung cancer patients.